Table 2 Summary of differential testing for DNA methylation, RNA, and protein expression

From: Impact of BRCA mutations, age, surgical indication, and hormone status on the molecular phenotype of the human Fallopian tube

Contrasted Groups

Model

DMRs (Stouffer’s Pval <0.05)

Differentially Expressed Genes

Differentially Expressed Proteins

BRCA DIFFERENCES

BRCAm vs. Non-BRCAm

~BRCAm

10

3524

92

BRCAm vs. Non-BRCAm

~BRCAm + % Stroma

5

1569

0

BRCAm vs. Non-BRCAm excl. postpartum

~ BRCAm + % Stroma

0

159

0

MENOPAUSE DIFFERENCES

Pre- vs. Post-menopause

~Menopause Status

36547

5826

966

Pre- vs. Post-menopause

~Menopause Status + % Stroma

164

696

4

Pre- vs. Post-menopause excl. postpartum

~Menopause Status + % Stroma

60

1769

0

  1. DMR = differentially methylated regions.